Financial Enhancement Group LLC Increases Stake in Danaher Co. (NYSE:DHR)

Financial Enhancement Group LLC grew its position in Danaher Co. (NYSE:DHRGet Rating) by 1.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,011 shares of the conglomerate’s stock after acquiring an additional 114 shares during the quarter. Financial Enhancement Group LLC’s holdings in Danaher were worth $3,230,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in DHR. City Holding Co. increased its stake in Danaher by 13.0% in the 1st quarter. City Holding Co. now owns 4,133 shares of the conglomerate’s stock worth $1,212,000 after buying an additional 475 shares during the period. RDA Financial Network increased its stake in Danaher by 73.4% in the 1st quarter. RDA Financial Network now owns 2,763 shares of the conglomerate’s stock worth $810,000 after buying an additional 1,170 shares during the period. Selective Wealth Management Inc. increased its stake in Danaher by 500.0% in the 1st quarter. Selective Wealth Management Inc. now owns 348 shares of the conglomerate’s stock worth $102,000 after buying an additional 290 shares during the period. Citizens Financial Group Inc RI increased its stake in Danaher by 5.7% in the 1st quarter. Citizens Financial Group Inc RI now owns 20,551 shares of the conglomerate’s stock worth $6,028,000 after buying an additional 1,101 shares during the period. Finally, 1900 Wealth Management LLC increased its stake in Danaher by 2.6% in the 1st quarter. 1900 Wealth Management LLC now owns 1,969 shares of the conglomerate’s stock worth $578,000 after buying an additional 50 shares during the period. Hedge funds and other institutional investors own 77.27% of the company’s stock.

Danaher Stock Down 4.0 %

NYSE:DHR opened at $281.78 on Wednesday. Danaher Co. has a fifty-two week low of $233.71 and a fifty-two week high of $331.68. The stock has a market capitalization of $204.98 billion, a P/E ratio of 33.19, a P/E/G ratio of 1.39 and a beta of 0.88. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.75. The company’s 50-day simple moving average is $278.50 and its 200-day simple moving average is $269.73.

Danaher (NYSE:DHRGet Rating) last released its quarterly earnings results on Thursday, July 21st. The conglomerate reported $2.76 earnings per share for the quarter, beating analysts’ consensus estimates of $2.35 by $0.41. The business had revenue of $7.75 billion for the quarter, compared to analysts’ expectations of $7.29 billion. Danaher had a net margin of 20.61% and a return on equity of 18.57%. The company’s revenue was up 7.4% compared to the same quarter last year. During the same period last year, the business earned $2.46 EPS. On average, equities analysts anticipate that Danaher Co. will post 10.4 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, September 30th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 0.35%. Danaher’s dividend payout ratio (DPR) is presently 11.78%.

Insider Buying and Selling

In related news, CEO Rainer Blair sold 25,000 shares of Danaher stock in a transaction that occurred on Monday, August 15th. The shares were sold at an average price of $300.00, for a total value of $7,500,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,739 shares in the company, valued at approximately $23,921,700. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Rainer Blair sold 25,000 shares of Danaher stock in a transaction that occurred on Monday, August 15th. The shares were sold at an average price of $300.00, for a total value of $7,500,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,739 shares in the company, valued at approximately $23,921,700. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Walter G. Lohr sold 3,906 shares of Danaher stock in a transaction that occurred on Friday, July 22nd. The stock was sold at an average price of $273.84, for a total transaction of $1,069,619.04. Following the completion of the sale, the director now owns 12,115 shares of the company’s stock, valued at $3,317,571.60. The disclosure for this sale can be found here. Insiders sold 40,906 shares of company stock worth $11,823,179 in the last three months. Corporate insiders own 11.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Evercore ISI reduced their price target on shares of Danaher from $320.00 to $280.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 5th. UBS Group raised their target price on shares of Danaher from $297.00 to $323.00 and gave the company a “buy” rating in a research report on Thursday, July 28th. Royal Bank of Canada raised shares of Danaher from a “sector perform” rating to an “outperform” rating and raised their target price for the company from $299.00 to $310.00 in a research report on Wednesday, June 1st. StockNews.com raised shares of Danaher from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 26th. Finally, KeyCorp cut their target price on shares of Danaher from $345.00 to $325.00 and set an “overweight” rating on the stock in a research report on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $320.73.

About Danaher

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.